ANGO
AngioDynamics Delivers Strong Fiscal Year 2026 Performance with 18% Med Tech Growth
AngioDynamics, a leading medical technology company, recently reported its Fiscal Year 2026 fourth quarter and full year earnings call, showcasing impressive growth and profitability. The company's strong performance in the med tech segment, which accounted for 47% of total revenue, demonstrates its successful strategy to transform into a